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Congenital heart disease 
Congenital heart disease (CHD) accounts for 28% of all major congenital anomalies.1 The 
worldwide incidence of CHD is estimated to 9 per 1,000 live births;2 moderate and severe 
forms are present in about 6 per 1,000 live births.3 Amongst all birth defects, CHD is the 
leading cause of illness and death in the infant age.4 However, the advances in diagnostic 
methods, medical, interventional and surgical therapy of infants and children with CHD have 
resulted in one of the largest survival increments in medical history.5-8 In developed countries, 
more than 90% of CHD patients are expected to survive the complete childhood.9, 10 Survival 
to adulthood varies with the severity of CHD: 96-98% of patients with mild and moderate CHD 
and 56% of patients with severe CHD survive to adult ages.11 The prevalence of patients with 
CHD in developed countries increased by >50% from 2000 to 2010.12  
Functionally single ventricle 
Approximately 25% of the infants with CHD are born with a so-called „critical CHD“4 and need 
of surgical or interventional treatment in the neonatal and infant age. Part of these patients 
has a functionally univentricular heart. This term includes all hearts in which one of the 
ventricles is anatomically or functionally inadequate, and the other, dominant ventricle has to 
support both the systemic and pulmonary circulation. Another common attribute of these 
hearts is that surgical therapy in the form of a biventricular correction is not achievable.13 
The group of functionally univentricular hearts includes many different anatomical variations. 
Generally, it is possible to differentiate the dominant ventricle into the left, right or 
undifferentiated ventricle.14 An anatomically single ventricle, without even a rudimentary part 
of the second ventricle, is very rare.15, 16 
Many different anatomical variants of the functionally single ventricle are described, the most 
common being tricuspid atresia, double inlet left ventricle, pulmonary atresia with an intact 
interventricular septum, unbalanced common atrioventricular canal and the hypoplastic left 





Physiologically, the dominant ventricle supplies the systemic and pulmonary circulation in 
parallel. This parallel circulation poses a strain on the functionally single ventricle, and it leads 
to hypoxemia due to mixing of the oxygen-saturated and oxygen-desaturated blood. The 
function of the single ventricle and the competence of the atrioventricular valves play a 
significant role in the univentricular circulation.  
The clinical picture of the newborns depends primarily on the amount of blood in the 
pulmonary circulation.17 In this way, the functionally univentricular hearts can be divided into 
three groups, depending on the balance between the systemic and pulmonary circulation in 
the newborn age: 
- balanced systemic and pulmonary circulation  
- few clinical symptoms13, 18 
- surgical treatment in the newborn age is not necessary 
- restrictive pulmonary circulation  
- main symptom is cyanosis 
- a systemic-to-pulmonary shunt in the newborn age 
- excessive pulmonary circulation  
- mainly symptoms of heart failure  
- without the obstruction of the systemic circulation Æ a pulmonary artery 
banding in the newborn age 
- with obstruction of the systemic circulation Æ a complex Norwood 
operation in the newborn age 
The surgical therapy of all types of the functionally univentricular heart has a common 
objective: separating the pulmonary and systemic bloodstream while using the pump function 
of the dominant ventricle for the systemic circulation. The surgical strategy includes three 
steps: 
- Step I: initial palliation in the newborn age for insuring unhindered systemic outflow 






- Step II: partial separation of the pulmonary and systemic bloodstreams by creating a 
superior cavopulmonary anastomosis, between 3-6 months of age 
- Step III: complete separation of the pulmonary and systemic circulation by connecting 
the inferior vena cava to the pulmonary artery and completing the so-called Fontan-
circulation, in the age of 18-48 months 
Hypoplastic left heart syndrome 
First described by Noonan and Nadas in 1958,19 hypoplastic left heart syndrome (HLHS) is the 
most common type of a functionally univentricular heart,20 with an incidence of 2 to 3 per 
10,000 births,21, 22 accounting for 1 – 3% of all CHD.23 HLHS is also one of the most complex 
and surgically challenging CHD. 
HLHS consists of a variety of cardiac anomalies characterised by a hypoplastic left ventricle, 
atresia or stenosis of the aortic and mitral valve, and hypoplastic ascending aorta and aortic 
arch Figure 1.24  
Newborns with HLHS are dependent on the persisting arterial duct, and the open atrial 
communication Figure 1.23 The oxygenated blood from the pulmonary veins flows from the left 
atrium over the open atrial septum into the right atrium („left-to-right shunting“) and mixes 
there with the desaturated blood from the systemic veins. The “mixed” blood flows then 
through the dominant right ventricle in the main pulmonary artery. A part of the blood volume 
goes again in the pulmonary circulation. The other part of the blood flows over the persistent 
arterial duct in the aorta and facilitates the retrograde perfusion of the upper body part and 







Figure 1. Hypoplastic left heart syndrome 
© 2014 Children's Hospital of Philadelphia 
https://www.chop.edu/conditions-diseases/hypoplastic-left-heart-syndrome-hlhs 
The systemic tricuspid valve is dysplastic approximately one-third of patients with HLHS, more 
commonly so in the presence of a non-atretic mitral valve.25 Bileaflet tricuspid valve is present 
in up to 12% of patients; quadricuspid valve, clefts, and accessory orifices are less common.25 
The size of the tricuspid annulus is usually on the upper range of normal or above. 
The theoretical work on surgical therapy of the HLHS started in the ‘60s and ‘70s26, 27 with 
several unsuccessful surgical attempts.28, 29 The first successful surgical treatment was 








The Norwood operation is usually performed during the first ten days of life. To avoid possible 
complications, the surgery should not be delayed beyond the 2-3 weeks of life.33, 34 
The goals of the Norwood operation Figure 2 are: 
- unobstructed systemic circulation  
- using the pulmonary valve for the systemic outflow 
- augmenting the aorta 
- unobstructed mixing of the blood from the pulmonary and the systemic veins 
- surgical widening of the atrial septal communication 
- optimal pulmonary blood flow for enabling the growth of the pulmonary arteries 
- systemic-to-pulmonary shunt implantation 
 
Figure 2. Norwood procedure 






Bidirectional superior cavopulmonary anastomosis 
The bidirectional superior cavopulmonary anastomosis (BSCPA) is performed in the age of 3-
6 months.35 The timing for BSCPA differs significantly among centres, but it should not be 
performed while the pulmonary vascular resistance exceeds 2-3 Wood units.36, 37  
During this operation, the superior vena cava is separated from the right atrium and sutured 
to the pulmonary artery Figure 3. The systemic-to-pulmonary shunt is divided. After BSCPA, 
unsaturated blood from the upper part of the body enters the pulmonary circulation without 
circulating through the heart. 
 
Figure 3. Bidirectional superior cavopulmonary anastomosis 
© 2014 Children's Hospital of Philadelphia 
https://www.chop.edu/treatments/staged-reconstruction-heart-surgery 
The goals of the BSCPA are: 
- partial separation of the pulmonary and systemic bloodstream 
- providing sufficient "low pressure" pulmonary perfusion  





Total cavopulmonary connection 
Total cavopulmonary connection (TCPC) is performed in the age of 18 to 36 months.38 Some 
centres perform Fontan completion at an older age with comparable outcomes.39  
The goal of the TCPC is the complete separation of the pulmonary and systemic circulation. 
This is achieved by disconnecting the vena cava inferior from the right atrium and suturing it 
to the pulmonary artery Figure 4. In this way, the desaturated blood from the lower body also 
flows to the pulmonary circulation without entering the heart.  
 
 
Figure 4. Total cavopulmonary connection 







Influence of bidirectional superior cavopulmonary anastomosis on the systemic right 
ventricle and the systemic tricuspid valve 
High-grade of tricuspid valve insufficiency is a known risk factor for early and late morbidity 
and mortality40, 41 in the patients with HLHS. The function of the tricuspid valve is influenced 
by the interaction of volume overload and consequent enlargement of the systemic right 
ventricle and the tricuspid annulus, morphological anomalies of the valve leaflets, and the 
pump-function of the systemic right ventricle.42 
The construction of BSCPA changes the origin of the pulmonary bloodstream and decreases 
the volume of blood entering the systemic right ventricle.43 The reduction of the ventricular 
volume slows down the dilation of the tricuspid valve annulus.44 It has been reported that the 
grade of insufficiency of the atrioventricular valve in patients with a functionally univentricular 
heart can decrease after BSCPA, without simultaneous valve surgery.45  
We aimed to evaluate the effect of BSCPA and consequent reduction of volume load on the 
systemic right ventricle and the systemic tricuspid valve in patients with HLHS.  
Re-coarctation after the Norwood operation 
Early mortality following the Norwood operation in patients with HLHS has declined in the 
past years to approximately 10-22%.46 Serious complications which might occur after the 
Norwood operation are excessive or inadequate pulmonary blood flow, impairment of 
coronary artery perfusion, and neoaortic arch obstruction.47 The reported rate of re-
coarctation of the aorta is 10-36%.48, 49 Re-coarctation is associated with decreased ventricular 
function and tricuspid regurgitation, and consequent morbidity and mortality.50 Recurrent or 
residual aortic arch obstruction may be technique and materials dependent.51-53  
Our study aimed to determine the incidence, evaluate the risk factors, and analyse therapy 








Unloading of right ventricle by bidirectional superior cavopulmonary anastomosis in 
hypoplastic left heart syndrome patients promotes remodeling of systemic right 
ventricle but does not improve tricuspid regurgitation  
Jelena Kasnar-Samprec*, Andreas Kühn*, Jürgen Hörer, Manfred Vogt, Julie Cleuziou, Rüdiger 
Lange, Christian Schreiber 
J Thorac Cardiovasc Surg. 2012 Nov;144(5):1102-8.  
* Equally contributing authors 
Ziel: Das Ziel unserer Studie war die Beurteilung des Effekts der bidirektionalen superioren 
cavopulmonalen Verbindung (BSCPA) zur Verringerung der Volumenbelastung des 
systemischen rechten Ventrikels und der systemischen Trikuspidalklappe bei Patienten mit 
hypoplastischem Linksherz Syndrom (HLHS).  
Patienten und Methoden: Neunzig aufeinanderfolgende Patienten mit HLHS, die die 
frühpostoperative Periode nach BSCPA überlebt hatten, wurden analysiert. Zwei 
Echokardiogramme wurden durch einen erfahrenen Spezialisten bewertet: eines vor der 
BSCPA und das zweite beim letzten Follow-Up vor der totalen cavopulmonalen Anastomose. 
Die folgenden Parameter wurden beurteilt: Grad der Trikuspidalklappeninsuffizienz, die 
Morphologie der Trikuspidalklappe bei Klappeninsuffizienz, der Durchmesser des 
Trikuspidalklappenannulus, tricuspid annular plane systolic excursion (TAPSE) und die 
rechtsventrikuläre Pumpfunktion.  
Ergebnisse: In den Echokardiogrammen, die im Median fünf Tage vor der BSCPA durchgeführt 
wurden, gab es keine Trikuspidalklappeninsuffizienz bei 11 Patienten, minimale bei 37 
Patienten, geringgradige bei 24 Patienten und mittelgradige bei 11 Patienten. In den 
Echokardiogrammen, die im Medianalter von 17 Monate durchgeführt wurden, gab es keine 
Trikuspidalklappeninsuffizienz bei 14 Patienten, minimale bei 37 Patienten, geringgradige bei 
21 Patienten, mittelgradige bei 6 Patienten und hochgradige bei 5 Patienten. Der Unterschied 
zwischen der Trikuspidalklappeninsuffizienz vor und nach der BSCPA war statistisch nicht 





Trikuspidalklappeninsuffizienz hatten eine morphologisch auffällige Trikuspidalklappe, mit 
einem Prolaps des anterioren Segels und/oder einer Restriktion des posterioren Segels.   
Der Durchmesser des Trikuspidalklappenannulus ist nach der BSCPA in Patienten mit 
mittelgradigen und hochgradigen Trikuspidalklappeninsuffizienz gleichgeblieben; bei den 
verbliebenen Patienten ist er kleiner geworden.  
Vor der BSCPA war das Verhältnis von TAPSE zu Alter bei allen Patienten ähnlich. Nach der 
BSCPA war das Verhältnis von TAPSE zu Alter bei Patienten mit mittelgradiger oder 
hochgradiger Trikuspidalklappeninsuffizienz größer als beim Rest der Patienten.  
Die Funktion des systemischen rechten Ventrikels war normal in 95% der Patienten vor der 
BSCPA und 87% der Patienten nach der BSCPA. Die postoperative Pumpfunktion des rechten 
Ventrikels war nicht abhängig vom Durchmesser des Trikuspidalklappenannulus.  
Kommentar: In unserer Studie hat sich nach BSCPA der Grad der 
Trikuspidalklappeninsuffizienz nicht geändert. Die relative Größe des 
Trikuspidalklappenannulus hat sich verkleinert, bedingt wahrscheinlich durch die verringerte 
Volumenbelastung nach der BSCPA. Bei Patienten mit mittelgradiger und hochgradiger 
Trikuspidalklappeninsuffizienz hat sich der Annulus nicht verändert und war größer als beim 
Rest der Patienten. Die Segel der systemischen Trikuspidalklappe waren nur selten normal bei 
Patienten mit mittelgradiger und hochgradiger Klappeninsuffizienz.  
Nach der BSCPA war TAPSE nur bei Patienten mit weniger als moderater 
Trikuspidalklappeninsuffizienz signifikant kleiner. TAPSE ist direkt proportional zur Vorlast des 
rechten Ventrikels: diese ist vor der BSCPA höher als danach. TAPSE ist in Präsenz einer 
mittelgradigen oder hochgradigen Trikuspidalklappeninsuffizienz größer, weil der Unterschied 
zwischen systolischem und diastolischem rechtsventrikulären Volumen größer ist.   
In unserer Studie war die Prävalenz einer eingeschränkten rechtsventrikulären Pumpfunktion 
nach der BSCPA größer als präoperativ. Eine mögliche Erklärung dafür ist, dass der 
morphologisch rechte Ventrikel beim HLHS den systemischen Kreislauf unterstützen muss. 
Um eine Erklärung für dieses Phänomen zu finden, müssten weitere Studien die genaue 
Morphologie und Funktion des systemischen rechten Ventrikels und dessen Interaktion mit 





Schlussfolgerung: Unsere Ergebnisse haben gezeigt, dass weniger Volumenbelastung durch 
BSCPA den Durchmesser der systemischen Trikuspidalklappe verringern kann, ohne dass es 
zwingend zu einer Verringerung der Insuffizienz der Trikuspidalklappe führt. Man kann 
vermuten, dass sich der Grad der Trikuspidalklappeninsuffizienz nach der BSCPA ohne 
chirurgische Behandlung nicht ändern wird. Eine Trikuspidalklappenrekonstruktion sollte 










Recoarctation after the Norwood I procedure for hypoplastic left heart syndrome: 
incidence, risk factors, and treatment options 
Julie Cleuziou, Jelena Kasnar-Samprec, Jürgen Hörer, Andreas Eicken, Rüdiger Lange, Christian 
Schreiber.  
Ann Thorac Surg. 2013 Mar;95(3):935-40. 
Ziel: Das Ziel unserer Studie war die Feststellung der Inzidenz, die Evaluierung der 
Risikofaktoren, sowie die Analyse der Therapieoptionen für die Recoarctation nach einer 
Norwood Operation bei Patienten mit hypoplastischem Linksherz Syndrom (HLHS).   
Patienten und Methoden: In dieser Studie wurden 124 HLHS Patienten mit durchgeführter 
Norwood Operation analysiert. Die folgenden Faktoren waren in der Risikoanalyse 
eingeschlossen: Alter, Gewicht, Geschlecht, Durchmesser der nativen Aorta, chirurgische 
Technik und Patchmaterial für die Rekonstruktion der Aorta. In der Angiographie vor der 
bidirektionalen superioren cavopulmonalen Anastomose (BSCPA) wurde der Druckgradient 
zwischen der Aorta ascendens und der Aorta descendens, sowie die Notwendigkeit einer 
Dilatation der Recoarctation festgestellt. 
Ergebnisse: Eine Recoarctation ist bei 13% der Patienten, durchschnittlich 6.4±5 Monate nach 
der Norwood Operation diagnostiziert worden. Die geschätzte Freiheit von der Recoarctation 
nach der Norwood Operation lag bei 89.5% nach 6 Monate, 88.2% nach 12 Monate und 84.9% 
nach 10 Jahren.   
In der univariaten Analyse hat keiner der analysierten morphologischen oder chirurgischen 
Faktoren das Einstehen einer Recoarctation beeinflusst.  
Der durchschnittliche Druckgradient bei Patienten mit einer Recoarctation lag bei 24±16 
mmHg und damit signifikant höher als bei den Patienten ohne Recoarctation. Ein Patient 
verstarb vor der Therapie der Recoarctation. Bei den restlichen 12 Patienten mit 
Recoarctation wurde eine Ballondilatation bei 10 Patienten und eine Operation bei 2 
Patienten durchgeführt. Nach der interventionellen oder chirurgischen Therapie hat sich der 





Kommentar: In unserer Studie war die Inzidenz einer Recoarctation nach einer Norwood 
Operation bei Pateinten mit HLHS mit 13% niedrig.  
Obwohl das Patchmaterial einer der vermuteten Risikofaktoren für eine Recoarctation ist, 
konnte das unsere Studie nicht bestätigen. Keiner der analysierten morphologischen oder 
chirurgischen Faktoren hat das Einstehen einer Recoarctation signifikant beeinflusst.  
Die Therapieoptionen für eine Recoarctation sind interventionelle (Ballondilatation, Stent- 
Implantation) und chirurgische Prozeduren. Nach Ballondilatationen sind keine 
Komplikationen entstanden. Bei einigen Patienten musste aber eine Re-Dilatation vor der 
totalen cavopulmonalen Anastomose durchgeführt werden. Es traten keine Komplikationen 
nach chirurgischer Revision der Recoarctation auf.   
Schlussfolgerung: Eine niedrige Rate der Recoarctation nach der Norwood Operation bei HLHS 
Patienten ist durch Standardisierung der chirurgischen Technik mit einer kompletten 
Resektion des Ductus-Gewebe und einer zusätzlichen Erweiterung der distalen Anastomose 
erreichbar. Eine Recoarctation kann bei der Feststellung der Diagnose durch 
Ballonangioplastie erfolgreich behandelt werden. Eine chirurgische Therapie der 






Unloading of right ventricle by bidirectional superior cavopulmonary anastomosis in 
hypoplastic left heart syndrome patients promotes remodeling of systemic right 
ventricle but does not improve tricuspid regurgitation  
Jelena Kasnar-Samprec*, Andreas Kühn*, Jürgen Hörer, Manfred Vogt, Julie Cleuziou, Rüdiger 
Lange, Christian Schreiber 
J Thorac Cardiovasc Surg. 2012 Nov;144(5):1102-8.  
* Equally contributing authors 
Objective: Our study aimed to evaluate the effect of bidirectional superior cavopulmonary 
anastomosis (BSCPA) and consequent reduction in volume load on the systemic right ventricle 
and the systemic tricuspid valve in patients with hypoplastic left heart syndrome (HLHS).  
Patients and methods: Ninety consecutive patients with HLHS, who were early-survivors after 
BSCPA were included in the study. Two ultrasound examinations from each patient were re-
evaluated by an experienced paediatric cardiologist: one prior to BSCPA and the second prior 
to completing the Fontan circulation. The degree of tricuspid regurgitation, the morphology 
of the systemic tricuspid valve, the diameter of the tricuspid annulus, tricuspid annular plane 
systolic excursion (TAPSE), and the right ventricular function were noted. 
Results: In the echocardiograms performed in median five days before BSCPA, tricuspid 
regurgitation was absent in 11 patients, trivial in 37 patients, mild in 24 patients, and 
moderate in 11 patients. In the echocardiograms performed in age of median 17 months, 
tricuspid regurgitation was absent in 14 patients, trivial in 37 patients, mild in 21 patients, 
moderate in 6 patients, and severe in 5 patients. The change in grade of tricuspid regurgitation 
before and after BSCPA was not statistically significant. Most of the patients with a moderate 
and severe tricuspid regurgitation had a structurally abnormal tricuspid valve, most commonly 
a prolapse of the anterior leaflet and/or a restriction of the posterior leaflet. 
The diameter of the tricuspid valve annulus stayed the same after BSCPA in patients with 





Prior to BSCPA, the TAPSE/age ratio was similar in all patients. After BSCPA, the TAPSE/age 
ratio was larger in patients with postoperative moderate or severe tricuspid regurgitation, 
than in the remaining patients.  
The function of the systemic right ventricle was normal in 95% of the patients before BSCPA 
and 87% of the patients after BSCPA. The postoperative function of the right ventricle was not 
dependent on the diameter of the tricuspid annulus. 
Comment: In our study, the grade of the tricuspid valve regurgitation did not change after the 
BSCPA. The diameter of the tricuspid annulus decreased, most likely due to a reduction of the 
volume load. In patients with moderate or severe tricuspid regurgitation, the annulus did not 
change and was larger than in the remaining patients. The leaflets of the systemic tricuspid 
valve were only rarely described as normal in patients with moderate or severe regurgitation. 
TAPSE was significantly reduced after BSCPA only in patients without moderate or severe 
tricuspid regurgitation.   
In our cohort, more patients had a reduced function of the systemic RV after BSCPA than 
before the operation. A partial explanation is that a morphologically right ventricle must 
sustain the systemic blood flow in patients with HLHS. Additional investigation of the 
morphology and function of the systemic right ventricle and its interaction with the 
hypoplastic left ventricle are necessary to explain this result. 
Conclusion: Our study suggests that the reduction in volume load reduces the size of the 
systemic tricuspid annulus, without necessarily influencing the valve regurgitation. It can be 
assumed that the degree of tricuspid regurgitation won’t change after the BSCPA without 
valve surgery. Therefore, tricuspid valve repair should be carefully discussed prior to 








Recoarctation after the Norwood I procedure for hypoplastic left heart syndrome: 
incidence, risk factors, and treatment options 
Julie Cleuziou, Jelena Kasnar-Samprec, Jürgen Hörer, Andreas Eicken, Rüdiger Lange, Christian 
Schreiber.  
Ann Thorac Surg. 2013 Mar;95(3):935-40. 
Objective: Our study aimed to determine the incidence, evaluate risk factors, and analyse 
therapy options of re-coarctation after Norwood operation in patients with hypoplastic left 
heart syndrome (HLHS). 
Patients and methods: One hundred twenty-four consecutive patients with HLHS who 
underwent the Norwood operation were included in the study. The following factors were 
included in the risk analysis:  age, weight, gender, the diameter of the native ascending aorta, 
the surgical technique and the patch material. The difference in the pressure in the ascending 
and the descending aorta, as well as the need for dilatation of a re-coarctation, was noted on 
the angiography before bidirectional superior cavopulmonary anastomosis (BSCPA). 
Results: Re-coarctation was diagnosed in 13% of the patients at a mean time of 6.4±5 months 
following the Norwood operation. Freedom from re-coarctation was 89.5% at six months, 
88.2% at 12 months and 84.9% at ten years. 
In the univariate analysis, none of the examined morphologic or surgical factors influenced 
the development of a re-coarctation.  
The mean pressure difference in patients with a re-coarctation was 24±16 mmHg, and 
significantly higher than in patients without a re-coarctation. One patient demised before the 
re-coarctation could be treated. In the remaining 12 patients, balloon angioplasty was 
performed in 10 patients while two required surgical relief of the obstruction. After the 
interventional or surgical procedure, the difference in pressures significantly decreased to 
6.3±4 mmHg. 
Comment: In our cohort, the incidence of re-coarctation after the Norwood operation in HLHS 





Although the patch material is one of the implicated risk factors for developing a re-
coarctation after a Norwood operation in the HLHS patients, our study could not confirm this. 
All of the examined patient characteristics and surgical factors did not significantly influence 
the recurrence of an aortic arch obstruction. 
Treatment options for re-coarctation include interventional (balloon angioplasty, stent 
implantation) and surgical procedures. No complications occurred after balloon angioplasty. 
However, several patients had to undergo a re-dilatation prior to total cavopulmonary 
connection. No complications occurred after the surgical relief of the re-coarctation  
Conclusion: A low frequency of re-coarctation following the Norwood procedure in HLHS 
patients can be accomplished using a standardised surgical technique which includes 
complete resection of the arterial duct and a careful broadening of the anastomosis at the 
distal end of the descending aorta. A re-coarctation can be treated successfully by balloon 
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